Medical devices, healthcare technology and the business of care
510(k) clearance · K261733

Ligence Heart

UAB Ligence · Decision date Oct 7, 2026

MEDTECHLEDGER EXPLANATIONK261733

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision for Ligence Heart, a 510(k) submitted by UAB Ligence of Kaunas, Lithuania, under number K261733. The decision date is 2026-10-07, with the application received 05/26/2026. The device falls under regulation 892.2050 with classification product code QIH, listed as Automated Radiological Image Processing Software, and the review panel and medical specialty are both Radiology. The submission is a Traditional 510(k) that was not reviewed by a third party and is not a combination product.

SESE means the device was cleared as substantially equivalent to a predicate; it is not a PMA approval. The record shows no authorized Predetermined Change Control Plan, so no predetermined modification scope is described. The public record does not state the specific components, software functions, or changed items reviewed, the predicate device, or any indications for use, and no summary or clinical evidence is included here. Those details would need to come from the underlying FDA documents rather than this database entry.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Radiology
Decision date
Oct 7, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K261733
Regulatory pathway
510(k) premarket notification
Applicant
UAB Ligence
Product code
QIH
Decision code
SESE
Decision date
Oct 7, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Automated Radiological Image Processing Software.

Applicant
UAB Ligence
Product code
QIH
FDA device class
2

FDA decision timeline

  1. K261733 received

    Application receipt date recorded by FDA.

  2. K261733 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code QIH

Product / regulatory recordCompanyPathwayDecision dateSource
Clever OneK260372
Ewoosoft Co., Ltd.510(k) clearanceNov 4, 2026FDA
Peek Health, S.A.510(k) clearanceNov 4, 2026FDA
AVICENNA.AI510(k) clearanceOct 19, 2026FDA
NeuroDRK262134
Deep Reasoning Ai, Inc.510(k) clearanceOct 7, 2026FDA
Medis Medical Imaging Systems BV510(k) clearanceOct 5, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

UAB Ligence

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Kaunas

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records